• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Mallinckrodt imaging revenues drop in Q1

Article

Despite overall higher earnings in its three business segments combined, healthcare giant Mallinckrodt saw a decline in year over year sales and revenues within its imaging division during the first quarter of 2000 (end-September). The St. Louis-based

Despite overall higher earnings in its three business segments combined, healthcare giant Mallinckrodt saw a decline in year over year sales and revenues within its imaging division during the first quarter of 2000 (end-September). The St. Louis-based company reported total sales of $614 million for the quarter, a 4% increase over sales of $592 million for the same quarter a year ago. Net earnings for the quarter were $38 million, up 19% from first quarter 1999 earnings of $32 million. Mallinckrodt chairman and CEO C. Ray Holman attributed the improvement in profitability to stronger sales of its pulse oximetry, radiopharmaceutical, and pharmaceutical products.

However, Mallinckrodt’s imaging group reported a 1% decrease in year over year revenues for the quarter, due primarily to lower sales of its x-ray contrast media and diagnostic catheter products. The imaging division recorded $182 million in sales, compared to $184 million for the first quarter of 1999. Quarterly earnings for the division fell 24% to $23 million from earnings of $31 million for the same quarter a year ago.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.